Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Understand wash sale rules for index funds and how to rebalance without triggering disallowed losses or tax penalties.
17,228 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
New data shows wealth grows more from steady saving and patient investing than from big salaries. The piece outlines ...
A top investor argues the vast US financial economy is due for a shift into the physical economy, centered on metals ...
As energy markets shift, investors must decide between EQT's pure-play gas model and Occidental's global oil mix. Thi...
Tokenized stocks emerge altcoin as a lifeline for investors seeking real-world asset exposure, even as traditional al...
A leading manager weighs the case for broad crypto exposure after investors rejected crypto basket ETFs. Early demand...
As markets ride a strong rally tied to policy expectations, a shift could come fast. This in-depth guide explains how...
Kensho Clean Power ETF (CNRG) surged 68% over the last year but fell 9% in February, as traders await a Fed signal th...
Quantum computing could reshape many industries, but is IonQ stock your ticket to millionaire status? This guide expl...
A quiet road, a moment of confusion, and a spotlight on money. This piece translates a high-profile misstep into acti...
A little-known international ETF is quietly outperforming the S&P 500 this year, riding a multi-factor strategy and l...
Six ETFs now cover the entire grid-resilience thesis, from hardware and software to infrastructure and energy metals,...